- A slimming aid made from a southern African cactus is set to be developed by UK firm Phytopharm and Unilever
- Phytopharm will receive an initial fee of £6.5m from Unilever - out of a potential total of £21m - as well as future royalties on product sales
- Under the deal, production of the Hoodia cactus at Phytopharm's nursery in South Africa will also rise from eight million plants to potentially hundreds of millions
- The firm had initially hoped to market a slimming drug from Hoodia with Pfizer
